Photo: Reuters
SYDNEY (Reuters) - Asian shares were mixed on Thursday after a choppy day of Wall Street trade, thanks in part to a disappointing U.S. jobs report, while the greenback languished near 2-1/2 year lows on growing optimism of a coronavirus vaccine.
Britain became the first Western country to approve a COVID-19 vaccine, with 800,000 doses of the Pfizer and BioNTech vaccine available for those at high risk starting next week.
The U.S. Food and Drug Administration is holding its advisory committee meeting next week, while New York Governor Andrew Cuomo has said the state's first delivery, enough for 170,000 residents, is expected on Dec 15.
The dollar index slipped to two-and-half year low of 90.987 on Wednesday and last stood at 91.048.
Hopes of a fiscal support package in the United States also boosted investor optimism. But share traders were less enthused.
MSCI's broadest index of Asia-Pacific shares outside of Japan were barely changed following two straight days of gains.
Japan's Nikkei was 0.2% weaker while South Korea's KOSPI was flat and Australia's benchmark index was slightly higher.
Chinese shares opened a tad lower, with the blue-chip CSI300 index off 0.03%.
Read more from the original article here:
면책 조항: 본 게시글에 표현된 견해는 전적으로 작성자의 견해이며 Followme의 공식 입장을 대변하지 않습니다. Followme는 제공된 정보의 정확성, 완전성 또는 신뢰성에 대해 책임을 지지 않으며, 서면으로 명시적으로 언급되지 않는 한 해당 내용을 기반으로 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다.
더 오래된 의견은 없습니다. 소파를 가장 먼저 잡으십시오.